Evidence map›Paper›PMID 33925613›Full record

ArticleBiomedicines2021

Promoting Neuronal Outgrowth Using Ridged Scaffolds Coated with Extracellular Matrix Proteins.

Ahad M Siddiqui, Rosa Brunner, Gregory M Harris, Alan Lee Miller, Brian E Waletzki, Ann M Schmeichel, Jean E Schwarzbauer, Jeffrey Schwartz, Michael J Yaszemski, Anthony J Windebank and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Research Progress on Biomaterials for Spinal Cord Repair.International journal of nanomedicine · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Open-Spaced Ridged Hydrogel Scaffolds Containing TiOInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Profilin Isoforms in Health and Disease - All the Same but Different.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Ahad M SiddiquiDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3334-1728
Rosa BrunnerProgram in Human Medicine, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
Gregory M HarrisDepartment of Molecular Biology, Princeton University, Princeton, NJ 08540, USA.ORCID 0000-0001-5594-9780
Alan Lee MillerDepartment of Orthopaedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3394-4019
Brian E WaletzkiDepartment of Orthopaedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Ann M SchmeichelDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Jean E SchwarzbauerDepartment of Molecular Biology, Princeton University, Princeton, NJ 08540, USA.ORCID 0000-0003-1012-7593
Jeffrey SchwartzDepartment of Chemistry, Princeton University, Princeton, NJ 08544, USA.
Michael J YaszemskiDepartment of Chemistry, Princeton University, Princeton, NJ 08544, USA.
Anthony J WindebankDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Nicolas N MadiganDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3652-7456
Mayo Clinic · USPrinceton University · USMayo Clinic in Arizona · USParacelsus Medical University · AT

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NRSA Training CoreTL1TR002380 · NCATS · MAYO CLINIC ROCHESTER · PI Felicity T. B. Enders, ANTHONY John WINDEBANK · 2017 to 2026
$6.0M
Fibronectin-dependent mechanisms governing the assembly of a definitive extracellular matrixR01AR073236 · NIAMS · PRINCETON UNIVERSITY · PI SCHWARZBAUER, JEAN E · 2018 to 2022
$1.7M
Bowen Foundation N/AKipnis Foundation N/AMayo Clinic Center for Regenerative Medicine N/ANCATS NIH HHS TL1 TR002380NCATS NIH HHS UL1 TR002377New Jersey Commission on Spinal Cord Research CSCR15IRG002NIAMS NIH HHS R01 AR073236Regenerative Medicine Minnesota N/A
6 · The paper itself

Abstract

Spinal cord injury (SCI) results in cell death, demyelination, and axonal loss. The spinal cord has a limited ability to regenerate, and current clinical therapies for SCI are not effective in helping promote neurologic recovery. We have developed a novel scaffold biomaterial that is fabricated from the biodegradable hydrogel oligo(poly(ethylene glycol)fumarate) (OPF). We have previously shown that positively charged OPF scaffolds (OPF+) in an open spaced, multichannel design can be loaded with Schwann cells to support axonal generation and functional recovery following SCI. We have now developed a hybrid OPF+ biomaterial that increases the surface area available for cell attachment and that contains an aligned microarchitecture and extracellular matrix (ECM) proteins to better support axonal regeneration. OPF+ was fabricated as 0.08 mm thick sheets containing 100 μm high polymer ridges that self-assemble into a spiral shape when hydrated. Laminin, fibronectin, or collagen I coating promoted neuron attachment and axonal outgrowth on the scaffold surface. In addition, the ridges aligned axons in a longitudinal bipolar orientation. Decreasing the space between the ridges increased the number of cells and neurites aligned in the direction of the ridge. Schwann cells seeded on laminin coated OPF+ sheets aligned along the ridges over a 6-day period and could myelinate dorsal root ganglion neurons over 4 weeks. This novel scaffold design, with closer spaced ridges and Schwann cells, is a novel biomaterial construct to promote regeneration after SCI.

Indexed as

axonal regenerationcell attachmentextracellular matrixneuronal outgrowthscaffoldsSchwann cellsspinal cord

Identifiers

PMID33925613
PMCPMC8146557
OpenAlexW3159761347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.